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UL21 of herpes simplex virus type 1 (HSV-1) is an accessory gene that encodes a compo-
nent of the tegument. Homologs of this protein have been identified in the alpha, beta, and
gamma herpesvirus subfamilies, although their functions are unclear. To clarify the func-
tions of UL21, we generated a UL21-null HSV-1 mutant. Growth analysis showed that the
synthesis of infectious UL21-null HSV-1 in glial cells was delayed and that the overall yield
was low. The plaque sizes of the UL21-null mutant were smaller than those of wild-type
HSV-1. We identified several candidate UL21-interacting proteins, including intermediate
filaments, by yeast two-hybrid screening. The distribution of glial fibrillary acidic protein
(GFAP), which is the main component of intermediate filaments, was altered in UL21-null
mutant-infected glial cells compared to wild-type virus-infected cells. These results will
help clarify the function of UL21 and broaden our understanding of the life cycle of HSV.
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INTRODUCTION
Herpes simplex virus type 1 (HSV-1) is an enveloped, large
DNA virus with a genome consisting of approximately 80 genes
that encode transcriptional regulatory proteins, capsid proteins,
enveloped glycoproteins, viral DNA replication proteins, and pro-
teins involved in the cleavage/packaging of viral DNA. However,
less than half of these genes are essential for replication of the virus
in culture (Roizman et al., 2006). The remainder are referred to as
accessory genes, which are dispensable for replication in cultured
cells but necessary for replication and spread in the host (Mori
and Nishiyama, 2006).
UL21 of HSV-1 is an accessory gene that encodes a 535-amino
acid component of the tegument (Baines et al., 1994). Homologs
of this protein have been identified in the alpha, beta, and gamma
herpesvirus subfamilies (Baer et al., 1984; Davison and Scott, 1986;
Chee et al., 1990). Most work on UL21 has been performed using
HSV-1 and pseudorabies virus (de Wind et al., 1992; Wagenaar
et al., 2001; Harper et al., 2010; Mbong et al., 2012). Absence of
UL21 results in a delay early in the HSV-1 replication (Mbong
et al., 2012), while processing of newly replicated viral DNA is
impaired in UL21-null pseudorabies virus (de Wind et al., 1992).
However, the role of this protein is still unclear.
Previously, we found that UL21 has sequence similarities with
tau (Takakuwa et al., 2001), a family of neuronal proteins that
associate with microtubules and enhance microtubule formation
and stability in vitro (Cleveland et al., 1977; Butner and Kirschner,
1991). UL21 promotes the outgrowth of long cellular processes
and associates physically with microtubules. In this way, UL21
may facilitate intracellular transport of the virus (Takakuwa et al.,
2001).
In this study, to clarify the functions of UL21, we generated a
UL21-null mutant and characterized its properties. Furthermore,
we screened for UL21-interacting host proteins using a yeast two-
hybrid system. We also compared the gene product distributions
in UL21-null mutant-infected and wild-type HSV-1-infected cells.
MATERIALS AND METHODS
CELLS AND VIRUSES
Vero (African green monkey kidney) and A172 (human glioblas-
toma) cells were obtained from the RIKEN BioResource Center
(Ibaraki, Japan). Vero cells were maintained in Dulbecco’s modi-
fied Eagle’s minimum essential medium supplemented with 5%
calf serum, 100 U/ml penicillin, 100µg/ml streptomycin, and
2 mM glutamine at 37˚C in 5% CO2. A172 cells were maintained
in RPMI1640 supplemented with 10% fetal calf serum at 37˚C in
5% CO2. Wild-type HSV-1 strain 17syn+ was kindly provided by
C. Cunningham. The virus stocks were propagated and titrated on
Vero cell monolayers.
ANTIBODIES
Anti-UL21 polyclonal rabbit antibodies were generated as
described previously (Takakuwa et al., 2001). The following poly-
clonal antibodies were used in this study: rabbit anti-glial fibrillary
acidic protein (GFAP; Cell Signaling Technology, Inc., Danvers,
MA, USA), rabbit anti-G protein-coupled receptor 56 (GPR56;
Medical and Biological Laboratories, Nagoya, Japan), rabbit anti-
neurofilament light polypeptide (NEFL; Cell Signaling Technol-
ogy, Inc.),Alexa Fluor®555-conjugated goat anti-mouse IgG1 (Life
Technologies, Grand Island, NY, USA), and Alexa Fluor®555-
conjugated goat anti-rabbit IgG (Life Technologies). Monoclonal
mouse antibodies against the following proteins were used: VP5,
β-actin (Abcam, Cambridge, UK), α-actinin-1 (Upstate, Temec-
ula, CA, USA), vimentin (Sigma, St. Louis, MO, USA), and β-actin
(Sigma). Normal goat serum was obtained from DAKO (Glostrup,
Denmark).
CONSTRUCTION OF THE UL21-NULL MUTANT
Two HSV-1 strains, UL21D and UL21R, were constructed. Viral
DNA from HSV-1 strain 17 was purified for use as the tem-
plate. The 1.0-kb long 5′ end of UL21, including the pro-
moter region, was amplified by PCR using a forward primer
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(5′-ccggaattcggctaagatccaccccaac-3′) carrying an EcoRI site and
a reverse primer (5′-cggggtacccgcgggcggcgacgtaacac-3′) carry-
ing a KpnI site. The amplified product was digested with
EcoRI and KpnI, and cloned into pEGFP-N3 (Invitrogen). Next,
the 1.0-kb long 3′ end of UL21, including the non-coding
region, was amplified by PCR using a forward primer (5′-
aaggaaaaaagcggccgcaagaccccaataaacg-3′) carrying a Not I site and a
reverse primer (5′-caacttaagctgcctctccgacctgc-3′) carrying an AflII
site. The amplified product was digested with Not I and AflII
and cloned into pEGFP-N3. The resultant plasmid, pEGFP-non-
coding-UL21, contained the EGFP gene flanking the 5′ and 3′ ends
of the non-coding region of UL21. The purified plasmid DNA
was linearized and cotransfected by the DEAE-dextran method
(Kawaguchi et al., 2001) onto rabbit skin cells with the purified
genome of HSV-1 strain 17. EGFP-positive plaques were purified
by three rounds of plaque purification; the stocks (100% purity)
were designated UL21D. In the mutant virus, the open reading
frame of UL21 was replaced with the coding region of EGFP.
For the construction of a revertant virus, the purified genome of
UL21D was cotransfected with a 2.3-kbp fragment containing the
wild-type HSV-1 UL21 gene onto rabbit skin cells. Three rounds
of plaque purification were performed to obtain reverted virus
stocks, which were designated UL21R.
EXTRACTION OF CELL LYSATES ANDWESTERN BLOT ANALYSIS
For Western blotting, cells were lysed with SDS sample buffer
containing 50 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 6%
2-mercaptoethanol, and 0.0025% bromophenol blue. The lysates
were separated by SDS-PAGE and transferred to polyvinylidene
difluoride membranes (Immobilon-P membranes; Millipore, MA,
USA). The membranes were blocked with blocking buffer (5%
skim milk and 0.1% Tween 20 in PBS) for 1 h at room temper-
ature. After incubation with appropriate primary antibodies for
1 h at room temperature, the membranes were incubated with
horseradish peroxidase-conjugated secondary antibodies, which
were subsequently detected using West-one (iNtRON Biotechnol-
ogy, Inc., Sungnam, Korea). The membrane was stripped with
Restore PLUS Western Blot Stripping Buffer (Thermo Fisher Sci-
entific Inc., Waltham, MA, USA), reblocked, and reprobed with
different primary antibodies.
ONE-STEP AND MULTISTEP GROWTH ASSAYS
Analyses of the one-step and multistep growth kinetics were per-
formed as described (Nozawa et al., 2005). Vero or A172 cells were
infected with each virus at multiplicities of infection (MOI) of 3 or
0.03 and incubated for 1 h at 37˚C to allow virus adsorption. The
culture medium was then replaced with newly prepared medium
containing 2% calf serum. The cells and supernatants were har-
vested at the indicated times after infection. The viral progeny
were titrated on Vero cells by plaque assays. Each experiment was
performed three times, and a representative result was shown.
YEAST TWO-HYBRID SCREEN
A ProQuest Two-Hybrid system with Gateway technology (Life
Technologies) was used (Parr et al., 2006; Wang and Chory, 2006).
The DNA fragment encoding amino acids 1-535 of UL21 was
subcloned in-frame into the pDBLeu vector and used as a bait.
A human fetal brain cDNA library was constructed with pPC86
and used as a prey vector. The yeast strain MaV203 were co-
transformed with the bait and prey vectors. Interactions were
tested on SD medium minus Leu, Trp, and His, and containing
40 mM 3-Amino-1,2,4-Triazole, according to the manufacturer’s
manual. Positive clones were selected by β–galactosidase activity.
The library plasmids from these colonies were rescued, amplified
by PCR, and sequenced (Ushijima et al., 2008).
IMMUNOFLUORESCENCE MICROSCOPY
Cells grown on coverslips were washed in PBS three times and
fixed for 10 min in 4% paraformaldehyde in PBS at room tem-
perature. For indirect immunofluorescence microscopy, the fixed
cells were permeabilized in 1% Triton X-100 in PBS for 5 min
at room temperature. The coverslips were inverted and touched
to droplets (20µl) of blocking buffer (4% goat serum and 1%
bovine serum albumin in PBS) on a clean Parafilm sheet for 45 min
at room temperature. Primary and Alexa Fluor®-conjugated sec-
ondary antibodies were diluted in blocking buffer and reacted
for 60 min at room temperature. The samples were examined
under a Zeiss LSM 510 confocal immunofluorescence microscope
(Yamauchi et al., 2008).
RESULTS
CONSTRUCTION OF THE UL21-NULL MUTANT AND ITS CONFIRMATION
We constructed a UL21-null mutant virus by homologous recom-
bination with an EGFP cassette flanking the 5′ and 3′ non-coding
regions of UL21 (designated UL21D). We also constructed a
reverted virus (UL21R). Viral DNA from UL21D and UL21R
were used to amplify the manipulated area by PCR; sequencing of
the products showed that the desired genetic manipulations had
been made. To confirm the deletion and reversion, Western blot
analyses were performed. The product of UL21 was not expressed
in UL21D-infected cells, but it was detected in both wild-type-
and UL21R-infected cells (Figure 1). VP5, a major capsid pro-
tein, was detected in UL21D-, wild-type-, and UL21R-infected
cells (Figure 1).
GROWTH KINETICS OF HSV-1 UL21
To determine whether the UL21-null mutant possessed a repli-
cation defect, we analyzed the growth kinetics of UL21D using
FIGURE 1 | Expression of UL21 and VP5. Vero cells were infected with
wild-type HSV-1 (wt), UL21D, or UL21R at an MOI of 3. The cells were
harvested at 6, 12, and 18 h post-infection and subjected to SDS-PAGE and
Western blotting, followed by detection with polyclonal rabbit or
monoclonal mouse antibodies.
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FIGURE 2 | Growth analyses of wild-type HSV-1, UL21D, and UL21R. (A)
One-step growth analysis. (B) Multistep growth analysis. Vero or A172 cells
were infected with wild-type HSV-1 (wt), UL21D, or UL21R at MOI of 3 (A) or
0.03 (B). At the indicated times post-infection, the infected cells and
supernatant were analyzed separately by plaque assay to determine the
intracellular and extracellular viral yields, respectively.
www.frontiersin.org November 2012 | Volume 3 | Article 394 | 3
Muto et al. Characteristics of UL21-null HSV-1
Vero and A172 cells. For one-step growth analysis, cells were
infected with wild-type HSV-1, UL21D, or UL21R at a high
MOI. In A172 cells, the intracellular and extracellular yields of
UL21D were reduced at 9–18 h post-infection and at 12–18 h
post-infection, respectively (Figure 2A). In contrast, no such
reduction was apparent in Vero cells (Figure 2A). For multi-
step growth analysis, cells were infected with virus at a low MOI.
Although the growth kinetics of UL21D were similar to those of
wild-type HSV-1 and UL21R in Vero cells, both the intracellular
and extracellular viral titers of UL21D were lower in A172 cells
(Figure 2B).
Next, we compared plaque morphologies. When Vero or A172
cells were infected with UL21D at a low MOI, the plaques
were smaller compared to both wild-type HSV-1 and UL21R
(Figure 3).
SCREENING FOR UL21-INTERACTING PROTEINS
A yeast two-hybrid screen of a human brain cDNA library using
UL21 as bait identified eight candidate UL21-interacting proteins:
α-1-actinin, GFAP, GPR56, MAX-like protein X, myelin basic pro-
tein, myo-inositol 1-phosphate synthase A1, NEFL, signal-induced
proliferation-associated 1 like 2, and vimentin.
We chose to further examine the cytoskeletal proteins α-1-
actinin, GFAP, NEFL, and vimentin because we previously showed
that UL21 protein interacts with microtubules (Takakuwa et al.,
2001). Additionally, GPR56 was chosen because this protein was
reported to colocalize with α-1-actinin in glioma cells (Shashidhar
et al., 2005).
FIGURE 3 | Plaque formation by UL21D in Vero and A172 cells. Vero or
A172 cells were infected with wild-type HSV-1 (wt), UL21D, or UL21R at an
MOI of 0.03. Viral plaques were photographed at 24 h post-infection. Bars
indicate 50µm.
UL21 DELETION ALTERED THE DISTRIBUTION OF INTERMEDIATE
FILAMENTS IN INFECTED A172 CELLS
Lastly, we investigated the distribution of α-1-actinin, GFAP,
GPR56, NEFL, and vimentin in UL21D- or wild-type
HSV-1-infected A172 cells (Figure 4). In UL21D-infected A172
cells, GFAP, a major intermediate filament in glial cells, accumu-
lated in the cytoplasm. This accumulation was not seen in wild-
type virus-infected cells. The distribution pattern of vimentin,
another intermediate filament protein, differed slightly between
UL21D- and wild-type virus-infected cells, although this could
have been caused by a delay in the cytopathic effects of the
UL21-null mutant.
DISCUSSION
Baines et al. (1994) who constructed the first UL21-null HSV-
1 mutant, found that UL21 was dispensable for replication in
cultured cells. They showed that the one-step growth of UL21-
null HSV-1 in Vero cells was similar to that of the wild-type,
but that HEL cells infected with the null mutant yielded approx-
imately three- to five-fold less virus than wild-type or revertant
virus-infected cells. Recently, Mbong et al. (2012) generated UL21-
null virus using a BAC system and showed that the yields of
their mutant virus in Vero cells were reduced as early as 6 h
post-infection compared to wild-type and UL21 repair viruses,
indicating that the absence of UL21 causes a delay in the produc-
tion of infectious virus. In this study, the yields of UL21D were
low at 9–18 h post-infection in glial cells, compared to the wild-
type and revertant viruses. Growth kinetics of UL21D at low MOI
were almost similar to those of wild-type HSV-1 and UL21R in
Vero cells. However, at 24 h post-infection, the yield of UL21D was
low, although final yields reached the level of wild-type HSV-1 and
UL21R (Figure 2B). The delay in production of infectious virus
accounts for the small plaque size seen in our study.
By yeast two-hybrid screening, we identified several proteins
that could interact with UL21. It is notable that some were
cytoskeletal proteins expressed in the central nervous system.
GFAP is the major intermediate filament of mature astrocytes, and
its relatively specific expression in these cells suggests an important
function in the central nervous system. However, its exact function
remains poorly understood, although GFAP may determine the
complex morphology of astrocytes (Messing and Brenner, 2003).
The influence of HSV infection on GFAP expression differs among
models. HSV infection results in upregulation of GFAP synthesis
in murine astrocytes (Carlucci et al., 1999), while its expression is
reduced by HSV in rabbit retinal astrocytes (Wakakura et al., 1987).
In contrast, HSV infection does not alter the general organization
of GFAP in astrocytes (McCarthy et al., 1990). In this study, the
results of our yeast two-hybrid screen indicated the association
of UL21 with GFAP. Furthermore, the distribution of GFAP was
altered in UL21-null mutant-infected A172 cells. These results sug-
gest that UL21 is associated with intermediate filaments, including
GFAP, and that HSV infection influences the organization of these
proteins. The UL21 gene product is a tegument protein that lines
the space between the envelope and nucleocapsid (Baines et al.,
1994) and is associated with capsid proteins (Harper et al., 2010).
UL21 protein binds to microtubules and promotes the outgrowth
of long cellular processes (Takakuwa et al., 2001; Roizman et al.,
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FIGURE 4 | Distribution of candidate proteins interacting with
UL21 in glial cells. A172 cells were infected with wild-type HSV-1
(wt) or UL21D at an MOI of 3. The cells were fixed at 12 or 18 h
post-infection, reacted with anti-α-1-actinin, -GFAP, -GPR56, -NEFL, or
-vimentin antibodies followed by Alexa Fluor®-conjugated secondary
antibodies, and examined under a confocal immunofluorescence
microscope. Arrows indicate GFAP accumulation. Bars indicate
20µm.
2006). The findings of these studies and our results suggest that the
function of UL21 may be associated with nucleocapsid transport
by means of its interaction with cytoskeletal proteins.
In conclusion, we generated UL21-null HSV-1 and character-
ized its properties. The synthesis of infectious UL21-null HSV-1
was delayed and its overall yields were low, in glial cells. Yeast
two-hybrid analysis identified several candidate UL21-interacting
proteins, including intermediate filaments. The distribution of
intermediate filaments was altered in UL21-null mutant-infected
glial cells compared to wild-type virus-infected cells. Although
further study is necessary, these results will help clarify the function
of UL21 and enhance our understanding of the HSV life cycle.
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